XRAY (XRAY) Q3 2026 earnings results
XRAY (XRAY) reported Q3 2026 results on Nov 5, 2026, 4:16:35 PM ET: adjusted EPS $0.29; revenue $836.00M. Outlook: Updated FY2026 outlook to approximately $3.5 billion in net sales and adjusted EPS of $1.20 to $1.30.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $0.29 | — | — |
| Revenue | $836.00M | — | — |
Analyst estimate: the average forecast before the release. No EPS comparison is shown when the company's reported basis (GAAP or adjusted) differs from the forecast's or no forecast was available.
Source
Figures from the SEC 8-K filing, released Nov 5, 2026, 4:16:35 PM ET. Nexqual published them 30 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 7.5% from $904.00M.
Stock reaction
The results came out after the market closed. XRAY closed at $9.46 on November 6, 2026, down 6.2% from its $10.09 close on November 5, 2026 before the results. Latest: $9.52 as of 11:40 AM ET, −5.7% since the pre-release close.
Questions and answers
Did XRAY beat earnings expectations?
Nexqual has no comparable analyst EPS estimate for this report (the forecast may be on a different basis than the reported GAAP or adjusted figure). Reported: adjusted EPS $0.29; revenue $836.00M.
What were XRAY's Q3 2026 earnings and revenue?
adjusted diluted EPS of $0.29 and revenue of $836.00M. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue fell 7.5% from $904.00M.
When did XRAY report Q3 2026 earnings?
Nov 5, 2026, 4:16:35 PM ET, in an SEC 8-K filing (Item 2.02).
How did XRAY stock react to the earnings?
The results came out after the market closed. XRAY closed at $9.46 on November 6, 2026, down 6.2% from its $10.09 close on November 5, 2026 before the results. Latest: $9.52 as of 11:40 AM ET, −5.7% since the pre-release close.
What did XRAY say about its outlook?
Updated FY2026 outlook to approximately $3.5 billion in net sales and adjusted EPS of $1.20 to $1.30.
More on XRAY
XRAY stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings November 5, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built November 10, 2026 at 16:40 UTC. Not investment advice.
Data source: Nexqual. Last updated: November 10, 2026 at 16:40 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt